210 related articles for article (PubMed ID: 34605588)
1. Mycobacteria-host interactions in human bronchiolar airway organoids.
Iakobachvili N; Leon-Icaza SA; Knoops K; Sachs N; Mazères S; Simeone R; Peixoto A; Bernard C; Murris-Espin M; Mazières J; Cam K; Chalut C; Guilhot C; López-Iglesias C; Ravelli RBG; Neyrolles O; Meunier E; Lugo-Villarino G; Clevers H; Cougoule C; Peters PJ
Mol Microbiol; 2022 Mar; 117(3):682-692. PubMed ID: 34605588
[TBL] [Abstract][Full Text] [Related]
2. Virulence-Associated Secretion in
Bar-Oz M; Meir M; Barkan D
Front Immunol; 2022; 13():938895. PubMed ID: 35880173
[TBL] [Abstract][Full Text] [Related]
3. Mice with lung airway ciliopathy develop persistent
Nava A; Hahn AC; Wu TH; Byrd TF
Front Immunol; 2022; 13():1017540. PubMed ID: 36505420
[TBL] [Abstract][Full Text] [Related]
4. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
5. Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
Das S; Garg T; Chopra S; Dasgupta A
J Antimicrob Chemother; 2019 May; 74(5):1317-1322. PubMed ID: 30753528
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterial Musculoskeletal Infections.
Hogan JI; Hurtado RM; Nelson SB
Thorac Surg Clin; 2019 Feb; 29(1):85-94. PubMed ID: 30454925
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-specific responses to human- and animal-adapted tubercle bacilli reveal pathogen and host factors driving multinucleated cell formation.
Queval CJ; Fearns A; Botella L; Smyth A; Schnettger L; Mitermite M; Wooff E; Villarreal-Ramos B; Garcia-Jimenez W; Heunis T; Trost M; Werling D; Salguero FJ; Gordon SV; Gutierrez MG
PLoS Pathog; 2021 Mar; 17(3):e1009410. PubMed ID: 33720986
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterial Musculoskeletal Infections.
Hogan JI; Hurtado RM; Nelson SB
Infect Dis Clin North Am; 2017 Jun; 31(2):369-382. PubMed ID: 28292541
[TBL] [Abstract][Full Text] [Related]
9. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy.
Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW
Front Immunol; 2021; 12():599641. PubMed ID: 33732233
[TBL] [Abstract][Full Text] [Related]
10. Assessment of current diagnostic algorithm for detection of mixed infection with Mycobacterium tuberculosis and nontuberculous mycobacteria.
Liang Q; Shang Y; Huo F; Xue Y; Li Y; Dong L; Li S; Pang Y
J Infect Public Health; 2020 Dec; 13(12):1967-1971. PubMed ID: 32335022
[TBL] [Abstract][Full Text] [Related]
11. Airway epithelial cells mount an early response to mycobacterial infection.
Barclay AM; Ninaber DK; van Veen S; Hiemstra PS; Ottenhoff THM; van der Does AM; Joosten SA
Front Cell Infect Microbiol; 2023; 13():1253037. PubMed ID: 37822359
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids.
Leon-Icaza SA; Bagayoko S; Vergé R; Iakobachvili N; Ferrand C; Aydogan T; Bernard C; Sanchez Dafun A; Murris-Espin M; Mazières J; Bordignon PJ; Mazères S; Bernes-Lasserre P; Ramé V; Lagarde JM; Marcoux J; Bousquet MP; Chalut C; Guilhot C; Clevers H; Peters PJ; Molle V; Lugo-Villarino G; Cam K; Berry L; Meunier E; Cougoule C
PLoS Pathog; 2023 Aug; 19(8):e1011559. PubMed ID: 37619220
[TBL] [Abstract][Full Text] [Related]
14. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages.
O'Leary S; O'Sullivan MP; Keane J
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):172-80. PubMed ID: 20889800
[TBL] [Abstract][Full Text] [Related]
15. Host-directed therapy to combat mycobacterial infections.
Kilinç G; Saris A; Ottenhoff THM; Haks MC
Immunol Rev; 2021 May; 301(1):62-83. PubMed ID: 33565103
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent Reporter DS6A Mycobacteriophages Reveal Unique Variations in Infectibility and Phage Production in Mycobacteria.
Mayer O; Jain P; Weisbrod TR; Biro D; Ho L; Jacobs-Sera D; Hatfull GF; Jacobs WR
J Bacteriol; 2016 Dec; 198(23):3220-3232. PubMed ID: 27672191
[TBL] [Abstract][Full Text] [Related]
17. Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.
Raju RM; Raju SM; Zhao Y; Rubin EJ
Emerg Infect Dis; 2016 Mar; 22(3):365-9. PubMed ID: 26886068
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of the Mycobacterium abscessus complexAuthors' replyClinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian AmazonBurden of non-tuberculous mycobacterial pulmonary disease in GermanyBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
Joob B; Wiwanitkit V
J Bras Pneumol; 2018; 44(5):434-435. PubMed ID: 30517343
[No Abstract] [Full Text] [Related]
20. The double-edged sword of Tregs in M tuberculosis, M avium, and M absessus infection.
Verma D; Chan ED; Ordway DJ
Immunol Rev; 2021 May; 301(1):48-61. PubMed ID: 33713043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
